In March 2025, the company announced new options for a direct-to-shopper giving of its Wegovy weight loss drug. The company founded a completely new pharmacy, known as NovoCare, which might charge consumers $499 a month for access to the drug, less than 50 percent the expense of the drug by other pharmaceutical distribution networks.[fifty three]Ry